Another such patient. After receiving replacement cells that produce insulin, Smith says, “I pray this gets to everyone. My life has changed.”
This is a definite potential maybe reported for one patient in China, so even a bit more than the usual caution is warranted. Trumpian blowback against anything Chinese, however, is not a maybe, but a vicious certainty. We already have the cancellation of research in the US into diabetes, cancer, Parkinson’s, Alzheimer’s, and other dread diseases, and the cancelling of all USAID medical assistance everywhere in the world, including HIV, malaria, and ebola.
Please find an event near you to take part in on July 17, Good Trouble day, in honor of John Lewis.
x
In a major scientific breakthrough, Chinese researchers may have developed a potential cure for Type 2 diabetes — a chronic condition affecting hundreds of millions globally. The treatment works by regenerating insulin-producing beta cells in the pancreas, effectively reversing the disease rather
[image or embed]
— Paul Eric Scannell (@pauleric70.bsky.social) July 5, 2025 at 6:35 PM
Wait a minute. I asked Google, and there is no such story.
Global pharma giants double down on China, betting on long-term growth
Trump isn’t complaining about this development either. He is merely continuing his intensely stupid trade war with China, which includes imports of Chinese-made pharmaceuticals. Fortunately the US gets only 21% of its insulin from China.
Stem Cell Therapy Achieves First-Ever Cure for Type 2 Diabetes
Researchers in Shanghai have claimed to have achieved the world’s first successful cure for type 2 diabetes using stem cell-derived islet transplantation.
Publishing their findings in the journal Cell Discovery, the team of scientists believe that this new therapy offers hope for the estimated 420 million people living with type 2 diabetes around the world. [1]
Read More
